SCHEMBL3500995

SCHEMBL3500995

NS(=O)(=O)c1cc(C(=O)NN2CC3=C4CCC(C4)C3C2)ccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.52
▸ LMNA P02545 1/20 0.52
▸ GLA P06280 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ CA1 P00915 14/20 0.47
▸ CA2 P00918 14/20 0.47
▸ CA12 O43570 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ CA3 P07451 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ CA4 P22748 1/20 0.47
▸ CA6 P23280 1/20 0.47
▸ CA5A P35218 1/20 0.47
▸ PTGS2 P35354 1/20 0.47
▸ CA7 P43166 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ CA13 Q8N1Q1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tripamide SCHEMBL1651231 0.75 KDM4E (0.59) KDM4ELMNAGLAMAPTHTT
Tripamide SCHEMBL49666 0.75 KDM4E (0.59) KDM4ELMNAGLAMAPTHTT
SCHEMBL9352633 0.70 CA1 (0.58) KDM4ELMNAGLAMAPTHTT
Clopamide SCHEMBL124598 0.69 KDM4E (1.00) KDM4ELMNAGLAMAPTHTT
Clopamide SCHEMBL1650071 0.69 KDM4E (1.00) KDM4ELMNAGLAMAPTHTT
SCHEMBL11883394 0.67 LMNA (0.52) KDM4ELMNAGLAMAPTHTT
Zidapamide SCHEMBL2109204 0.66 CA1 (0.63) KDM4ELMNAGLAMAPTHTT
SCHEMBL1272484 0.66 CA1 (0.71) CA1CA2
SCHEMBL31670530 0.65 CNR2 (0.73) KDM4ELMNAGLAMAPTHTT
SCHEMBL13687260 0.65 CA1 (0.66) KDM4ELMNAGLAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100184033-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY Lineage Cell Therapeutics, Inc. 2010-07-22 — — US disclosed
US-20080226601-A1 Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods UNIVERSITY OF ROCHESTER (US) 2008-09-18 — — US disclosed
Send feedback